Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers*

https://doi.org/10.1016/S0002-9610(97)00139-6Get rights and content

Abstract

Background

The OX-40 antigen is a cell surface glycoprotein in the tumor necrosis factor receptor family that is expressed primarily on activated CD4+ T cells. Selective target organ expression of the OX-40 receptor on autoantigen specific T cells has been found in autoimmune disease. In order to evaluate whether OX-40 is expressed on T cells from patients with nodal-draining carcinomas, OX-40 expression was assessed in tumor infiltrating lymphocytes (TILs), draining lymph node cells (DLNCs), and/or peripheral blood lymphocytes (PBLs) of 13 patients with head and neck squamous cell carcinomas and 9 patients with melanomas.

Methods

Cell phenotype was determined by fluorescence cell analysis using a monoclonal antibody to human OX-40, and CD4+ T cell lymphokine production was determined by reverse transcriptase-polymerase chain reaction (RT-PCR).

Results

Expression of the OX-40 receptor was found in as many as 31% of the TILs and as many as 28% of the DLNCs tested. Conversely, no OX-40 expression was found in PBLs. In addition, CD4+ T cells isolated from DLNCs (but not from TILs or PBLs) secreted a Th1 pattern of cytokines (IL-2, gamma Interferon). Co-culture of autologous CD4+ TILs with an MHC class II+ melanoma cell line transfected with OX-40 ligand cDNA resulted in T cell proliferation and in vitro tumor regression.

Conclusions

These findings suggest that OX-40+ CD4+ T cells isolated from tumors and their adjacent draining nodes may represent a tumorspecific population of activated T cells capable of mediating tumor reactivity. These cells may play an exploitable role in future trials of immunotherapy.

References (36)

  • MiltenyiS et al.

    High gradient magnetic cell separation with MACS

    Cytometry

    (1990)
  • ChomeczynskiP et al.

    Single step method of RNA isolation by acid guanidinium thiocyanated-pheno-chloroform extraction

    Ann Biochem

    (1987)
  • ChowYK et al.

    Immunity to TCR peptides in multiple sclerosis: T cell recognition of V beta 5.2. V beta 6.1. CDR2 peptides

    J Immunol

    (1994)
  • MiyawakiT et al.

    Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood

    J Immunol

    (1992)
  • Watanabe-FukunagaR et al.

    Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

    Nature

    (1992)
  • GodfreyWR et al.

    Identification of a human OX-40 ligand, a co-stimulator of CD4+ T cells with homology to tumor necrosis factor

    J Exp Med

    (1994)
  • BaumPR et al.

    Molecular characterization of immune and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34

    EMBO

    (1994)
  • MallettS et al.

    Characterization of the MRC OX-40 antigen of activated CD4 positive T lymphocytes—a molecule related to nerve growth factor receptor

    EMBO

    (1990)

    • Cited by (0)

    *

    Presented at the 87th Annual Meeting of the American Association for Cancer Research, Washington, DC, April 20–24, 1996.

    View full text
    Copyright © 1997 Published by Elsevier Inc.